SPACInsider Logo
AXIOS Sustainable Growth (AXAC.U) Prices Upsized $150M IPO
by Marlena Haddad on 2022-02-15 at 9:14pm

AXIOS Sustainable Growth Acquisition Corp. announced the pricing of its upsized $150 million IPO and its units are expected to begin trading on the NYSE under the symbol “AXAC.U” Wednesday, February 16.

The new SPAC intends to acquire a business engaged in agribusiness, plant-based proteins, food processing and AgTech based in Central and Eastern Europe. Axios Sustainable Growth is led by CEO Benedikt Fortig, CFO Dr. Ram Burgi-Krishnamurthy, and COO Anthony V. Raftpol.

Total SPAC deal count for 2022 year-to-date is now 40. This offering is expected to close on Friday, February 18.


I-Bankers Securities, Inc. is acting as the sole book-running manager of the offering. Skadden, Arps, Slate, Meagher & Flom LLP is serving as Issuer’s Counsel with Schiff Hardin LLP serving as Underwriter’s Counsel.  Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

Recent Posts
by Marlena Haddad on 2022-12-01 at 11:25am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News:  NYSE president says IPO proceeds fall more than 90% while Nasdaq president remains hopeful for 2023, and Giuliani brothers sell pharma stocks as they invest in biotech SPACs NYSE president says IPO proceeds fall...

by Marlena Haddad on 2022-12-01 at 10:02am

InterPrivate II Acquisition Corp. (NYSE:IPVA) disclosed this morning that it has restructured its bonus share agreement in connection to its proposed merger with carsharing marketplace Getaround. The parties previously agreed to reserve and set aside the bonus shares, consisting of 9,333,333 shares, to be allocated to the non-redeeming public stockholders, the designees of EarlyBirdCapital and the...

by Nicholas Alan Clayton on 2022-12-01 at 9:31am

Iris Acquisition Corp. (NASDAQ:IRAA) has entered into a definitive agreement to combine with biotech firm Liminatus at an enterprise value of $334 million. La Palma, California-based Liminatus is a clinical-stage drug developer working on a range of cancer treatments utilizing both preventative vaccines and CAR-T therapies. The combined company is expected to trade on the...

by Marlena Haddad on 2022-12-01 at 9:22am

Lakeshore Acquisition Corp. I (NASDAQ:LAAA) announced this morning that it has entered into a non-redemption agreement and amended its purchaser support agreement with initial shareholders in connection to its proposed merger with medical device company ProSomnus. The SPAC entered into non-redemption agreements with certain institutional investors for an aggregate of 200,339 shares of the purchaser. These investors...

by Nicholas Alan Clayton on 2022-11-30 at 6:01pm

The companies and sponsors of six SPAC deals are set to see their lock-ups expire before the end of the year. This is a relatively small monthly total as the wave of deals from 2020 and 2021 are still hitting this milestone. The list nonetheless includes some major names starting with Forafric (NASDAQ:AFRI), which is...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved